{
    "2021-04-09": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Pharma Stock Roundup: FDA Decision Delays for PFE, LLY, ABBV, AZN Vaccine Woes",
                "features": {
                    "keywords": [
                        "FDA",
                        "Decision",
                        "Delays",
                        "PFE",
                        "LLY",
                        "ABBV",
                        "AZN",
                        "Vaccine"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "The Zacks Analyst Blog Highlights: ServiceNow, AbbVie and Apple",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Analyst",
                        "Blog",
                        "ServiceNow",
                        "AbbVie",
                        "Apple"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "healthcare",
                        "consumer electronics"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Don't Race Out To Buy AbbVie Inc. (NYSE:ABBV) Just Because It's Going Ex-Dividend",
                "features": {
                    "keywords": [
                        "Race",
                        "Out",
                        "Buy",
                        "AbbVie",
                        "Ex-Dividend"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}